6929 — OrbusNeich Medical group Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual cashflow statement for OrbusNeich Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7.25	-1.32	21.8	49.6	42.4
Depreciation
Amortisation
Non-Cash Items	-1.02	8.45	4.2	-9.54	-4.89
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2.35	9.34	-6.44	-21.3	-29.7
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	12.7	20.5	23.4	23	13.1
Capital Expenditures	-3.76	-2.14	-3.33	-7.48	-11.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7.49	-3.08	-166	-44.8	19.9
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-11.2	-5.22	-169	-52.3	8.65
Financing Cash Flow Items	-5.34	-11.7	-2.77	-1.51	-2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-0.473	146	57.4	0.884	-19
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1.48	161	-89.2	-28.4	1.41